Pharmaxis has $25m cash, $10m PPE, and another $10m milestone payment looking likely by june.
Liabilities are really only $9m lease, $3m accounts payable and $2m other (excluded the $23m to novaquest because that is dependent on future revenues)
That gives me a rough book value of $45m - $14m = $31m
Currently pharmaxis is trading at $45m.
Question is, would you buy their entire portfolio of drugs for $14m?
I would. Boerhinger Ingelheim definitely would.
That's why I bought in today!
We are reaching book value soon
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.001(3.03%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $62.56K | 1.882M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 219277 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |